Advertisement
Singapore markets close in 6 hours 25 minutes
  • Straits Times Index

    3,171.17
    -16.49 (-0.52%)
     
  • Nikkei

    36,766.43
    -1,313.27 (-3.45%)
     
  • Hang Seng

    16,154.70
    -231.17 (-1.41%)
     
  • FTSE 100

    7,877.05
    +29.06 (+0.37%)
     
  • Bitcoin USD

    60,179.37
    -1,391.74 (-2.26%)
     
  • CMC Crypto 200

    1,249.00
    +363.46 (+38.34%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • Dow

    37,775.38
    +22.07 (+0.06%)
     
  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     
  • Gold

    2,420.00
    +22.00 (+0.92%)
     
  • Crude Oil

    85.57
    +2.84 (+3.43%)
     
  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     
  • FTSE Bursa Malaysia

    1,546.72
    +1.96 (+0.13%)
     
  • Jakarta Composite Index

    7,097.66
    -69.15 (-0.96%)
     
  • PSE Index

    6,491.54
    -31.65 (-0.49%)
     

Want to Grow Richer? These Stocks Have Doubled in the Past 5 Years

Want to Grow Richer? These Stocks Have Doubled in the Past 5 Years

Shares of AstraZeneca (NASDAQ: AZN) and Merck (NYSE: MRK) have both more than doubled over the last five years. With a $228 billion market capitalization, AstraZeneca is the sixth-largest pharmaceutical company in the world and the second-biggest international-based drugmaker behind Novartis (NYSE: NVS). As you'd guess would be the case for a major player in the pharmaceutical industry, the British drugmaker possesses a remarkable product portfolio.